Cecilia Jané, nurse of the ‘Servei de Medicina i Rehabilitació’ of Althaia (Xarxa assistèncial Universitària de Manresa) participated in the IV International Congress of Physiotherapy in Pelvi-perineology (SEFIP) , held in Barcelona from October 24 to 26, to present the preliminary results of the study on the efficacy of MOWOOT, the non-pharmacological and non-invasive solution to treat chronic constipation. The study, still ongoing, is the result of a … Continued

usMIMA, the team that developed the medical device MOWOOT, a non-drug and non-invasive solution to chronic constipation, signed a collaboration agreement with Biocat and Institut Guttmann. MOWOOT was developed after being inspired by a two-month stay at the Neurorehabilitation Centre Institut Guttmann during Biocat’s flagship program Design Health Barcelona. Ever since then the two institutions … Continued

After several months of work, preparation and dedication, usMIMA S.L., the company that developed MOWOOT, the non-pharmacological and non-invasive solution for constipation, has passed the certification audits for Quality Management Systems according to ISO 13485. This milestone adds to the recent achievement of CE certification as a class IIa medical device for MOWOOT, obtained last … Continued

Since the beginning of September this year MOWOOT has an office in London, UK. No, you did not read wrong. MOWOOT has been accepted to the MassChallenge accelerator UK and will have an office space in London during 3 months, which will be dedicated to learning and preparing the internationalization of the Spanish Medtech company. … Continued

Since last August, MOWOOT, the non-invasive, non-pharmacological solution to constipation without adverse effects, has CE certification as a Class IIa medical device. The CE marking guarantees that the equipment marketed complies with the essential requirements of the mandatory legislation. These requirements include tests for electrical safety, electromagnetic compatibility and usability, among other factors. The prestigious … Continued

usMIMA has been selected finalist in the Biotechnology and Health category of the Everis award 2015 of Fundación everis! The participation has been increased reaching over 400 international projects evaluated for the 2015 edition. In October the results and final classification for the award will be published. This article presents all the finalists and their … Continued

On Tuesday 9th of September Biocat organized the first European BioMedical Investors Day (EBID). The event took place at CCCB in Barcelona where 13 startups, from all over the world, had to present their projects to international investors in a 4 minutes pitch. In the picture above we can see Markus, one of usMIMA’s founders, … Continued

Short presentation video of usMIMA at “1 minute with” series promoted by Makers of Barcelona (MOB). We would like to thank Irene Soler, on behalf of Mayo Films, for recording the video and Biocat for their support during the dHealth Barcelona program and making this collaboration possible. Whatch the video!